Super-high levels of serum intact-parathyroid hormone and bone turnover markers descended with recuperating allograft function and a short-term high-dose methylprednisolone during preoperative period of renal transplantation: a retrospective cohort study.

Wenqing Xie, Junhao Lv, Chuncun Wei, Zhechi He, Suya Wang
Author Information
  1. Wenqing Xie: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  2. Junhao Lv: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  3. Chuncun Wei: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  4. Zhechi He: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.
  5. Suya Wang: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou, China.

Abstract

Background: Secondary hyperparathyroidism is an important factor of chronic kidney disease-mineral and bone disorder (CKD-MBD), which frequently results in maintenance dialysis patients having super-high levels of serum intact-parathyroid hormone (iPTH) and bone turnover markers (BTMs). This study aimed to investigate the immediate changes of iPTH and BTMs levels after renal transplantation during the perioperative period, and to explore the allograft function rapid recovery and the effect of high-dose glucocorticoids on serum iPTH and BTMs.
Methods: Between April 2018 and August 2021, a total of 346 Chinese kidney transplantation (KT) recipients (median age, 34.0 years; 236 males and 110 females; median dialysis duration, 12 months) were enrolled in this retrospective cohort study. The included patients had been undergoing maintenance dialysis for at least three months before transplant, and all of them accepted short-term high-dose methylprednisolone (MP) to prevent allograft rejection in the perioperative period. Allograft functions were evaluated and divided into different groups accorded to the CKD staging on the postoperative fifth day. Serum beta C-terminal crosslinking telopeptide of type I collagen (��-CTX), type 1N-terminal propeptide (P1NP), osteocalcin (OC), and iPTH were measured from fasting morning blood samples before surgery and on the postoperative fifth day with an electro-chemiluminescence immunoassay analyzer (2012; Roche Diagnostics).
Results: Among the participants, the graft functions were in CKD-II (n=134), CKD-III (n=137), CKD-IV (n=24), and CKD-V (n=51) after the postoperative fifth day. The changes of P1NP level [-95.8 (-84.0 to -2.4) ng/mL] and the OC level [-88.0 (-96.9 to -42.9) ng/mL] were significantly greater than those of the ��-CTX level [-62.3 (-73.6 to 0) pg/mL] and the iPTH level [-57.6 (-15.6 to 11.9) pg/mL] (P<0.001). In the CKD-V group, the changes of ��-CTX level [-0.7 (-43.15 to 0) pg/mL (+15.7%, P=0.61)] and the iPTH level [-8.69 (226.73 to 17.79) pg/mL (-22.8%), P=0.36] were less than those of the CKD-II group (P<0.001). ��-CTX, P1NP, and OC levels related with iPTH (r=0.413, 0.459, 0.482, respectively, P<0.001), and iPTH level with estimated glomerular filtration rate (eGFR; r=-0.474, P<0.001).
Conclusions: The super-high levels of BTMs and iPTH rapidly descended with recuperating allograft function during the short-term, indicating that improvement of current dialysis equipment to achieve clean up iPTH could more favorably decrease BMTs and improve CKD-MBD. Osteogenesis markers P1NP and OC still decreased and were not affected in CKD-V group, indicating that high-dose glucocorticoids might strongly inhibit osteoblast activity.

Keywords

References

  1. Int J Mol Sci. 2024 Feb 03;25(3): [PMID: 38339137]
  2. Kidney Int. 2014 Jan;85(1):166-73 [PMID: 23903367]
  3. Ann Transl Med. 2021 Nov;9(22):1635 [PMID: 34988144]
  4. Kidney Int Suppl (2011). 2017 Jul;7(1):1-59 [PMID: 30675420]
  5. Transplant Proc. 2020 May;52(4):1143-1146 [PMID: 32276835]
  6. J Nephrol. 2024 Jul;37(6):1497-1507 [PMID: 38032457]
  7. Arch Oral Biol. 2011 Apr;56(4):317-23 [PMID: 21112046]
  8. BMC Nephrol. 2019 Jun 14;20(1):218 [PMID: 31200654]
  9. J Bone Metab. 2019 Nov;26(4):213-224 [PMID: 31832387]
  10. PLoS One. 2018 Jun 18;13(6):e0199140 [PMID: 29912988]
  11. Transl Androl Urol. 2023 Apr 28;12(4):612-621 [PMID: 37181240]
  12. Osteoporos Int. 2017 Sep;28(9):2541-2556 [PMID: 28631236]
  13. Osteoporos Int. 2011 Feb;22(2):391-420 [PMID: 21184054]
  14. Adv Ther. 2019 Oct;36(10):2811-2824 [PMID: 31440982]
  15. Aust J Gen Pract. 2023 Jan-Feb;52(1-2):52-57 [PMID: 36796773]
  16. Adv Rheumatol. 2020 Feb 26;60(1):15 [PMID: 32102689]
  17. Kidney Int. 2019 Jun;95(6):1461-1470 [PMID: 30922664]
  18. Kidney Int Suppl. 2009 Aug;(113):S1-130 [PMID: 19644521]
  19. Transplant Proc. 2019 Sep;51(7):2330-2333 [PMID: 31402243]
  20. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):483-493 [PMID: 38030558]
  21. Orthop Surg. 2020 Apr;12(2):645-652 [PMID: 32064763]
  22. Clin Kidney J. 2020 Jun 26;13(3):307-321 [PMID: 32699616]

Word Cloud

Created with Highcharts 10.0.0iPTH0levellevelsBTMsOCbonedialysismarkersallograftfunctionhigh-dose��-CTXP1NPP<0001serumturnoverstudychangesrenaltransplantationperiodshort-termpostoperativefifthdayCKD-V96groupkidneyCKD-MBDmaintenancepatientssuper-highintact-parathyroidhormoneperioperativeglucocorticoidsmedianmonthsretrospectivecohortmethylprednisoloneAllograftfunctionstypeosteocalcinCKD-IIng/mL]pg/mL]pg/mLP=0descendedrecuperatingindicatingBackground:Secondaryhyperparathyroidismimportantfactorchronicdisease-mineraldisorderfrequentlyresultsaimedinvestigateimmediateexplorerapidrecoveryeffectMethods:April2018August2021total346ChineseKTrecipientsage34years236males110femalesduration12enrolledincludedundergoingleastthreetransplantacceptedMPpreventrejectionevaluateddivideddifferentgroupsaccordedCKDstagingSerumbetaC-terminalcrosslinkingtelopeptidecollagen1N-terminalpropeptidemeasuredfastingmorningbloodsamplessurgeryelectro-chemiluminescenceimmunoassayanalyzer2012RocheDiagnosticsResults:Amongparticipantsgraftn=134CKD-IIIn=137CKD-IVn=24n=51[-958-84-24[-88-96-42significantlygreater[-623-73[-57-1511[-07-4315+157%61][-869226731779-228%36]lessrelatedr=0413459482respectivelyestimatedglomerularfiltrationrateeGFRr=-0474Conclusions:rapidlyimprovementcurrentequipmentachievecleanfavorablydecreaseBMTsimproveOsteogenesisstilldecreasedaffectedmightstronglyinhibitosteoblastactivitySuper-highpreoperativetransplantation:glucocorticoid

Similar Articles

Cited By

No available data.